Group One Trading Portfolio holdings
AUM
$3.05B
1-Year Return
3.54%
This Quarter Return
+1.14%
1 Year Return
+3.54%
3 Year Return
+10.97%
5 Year Return
+15.65%
10 Year Return
+24.6%
AUM
$2.1B
AUM Growth
-$855M
(-29%)
Cap. Flow
-$1.03B
Cap. Flow
% of AUM
-48.78%
Top 10 Holdings %
Top 10 Hldgs %
24.64%
Holding
3,616
New
552
Increased
444
Reduced
696
Closed
635
Top Buys
| 1 |
Alibaba
BABA
|
+$83.1M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$43.5M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$25M |
| 4 |
JPMorgan Chase
JPM
|
+$24.6M |
| 5 |
Netflix
NFLX
|
+$23.9M |
Top Sells
| 1 |
Cigna
CI
|
+$127M |
| 2 |
Microsoft
MSFT
|
+$75.9M |
| 3 |
Apple
AAPL
|
+$70.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$57.2M |
| 5 |
Scorpio Tankers
STNG
|
+$43.1M |
Sector Composition
| 1 | Technology | 24.87% |
| 2 | Consumer Discretionary | 17.15% |
| 3 | Financials | 10.98% |
| 4 | Healthcare | 10.56% |
| 5 | Communication Services | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
PharmaCyte Biotech
PMCB
$6.86M
| $41.9K | ﹤0.01% |
+14,382
| New | +$41.9K |
|
1052
UGI
UGI
$7.38B
| $41.7K | ﹤0.01% |
+1,200
| New | +$41.7K |
|
|
ISEE
1053
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $41.7K | ﹤0.01% |
1,712
-50,953
| -97% | -$1.24M |
|
1054
Carisma Therapeutics
CARM
$16.4M
| $41.5K | ﹤0.01% |
13,397
-3,946
| -23% | -$12.2K |
|
1055
Rackspace Technology
RXT
$337M
| $41.4K | ﹤0.01% |
+22,039
| New | +$41.4K |
|
1056
Wallbox
WBX
$67.1M
| $40.5K | ﹤0.01% |
+414
| New | +$40.5K |
|
1057
Sonder
SOND
$21.6M
| $40.4K | ﹤0.01% |
2,666
-648
| -20% | -$9.81K |
|
1058
Local Bounti
LOCL
$48.2M
| $40.2K | ﹤0.01% |
+3,882
| New | +$40.2K |
|
1059
Children's Place
PLCE
$170M
| $40.1K | ﹤0.01% |
996
+656
| +193% | +$26.4K |
|
|
REFI
1060
Chicago Atlantic Real Estate Finance
REFI
$282M
| $39.8K | ﹤0.01% |
+2,949
| New | +$39.8K |
|
1061
The Beachbody Company, Inc. Class A Common Stock
BODI
$41.5M
| $39.8K | ﹤0.01% |
1,651
-234
| -12% | -$5.64K |
|
1062
Halozyme
HALO
$8.87B
| $39.8K | ﹤0.01% |
+1,041
| New | +$39.8K |
|
1063
CareDx
CDNA
$710M
| $39.7K | ﹤0.01% |
+4,340
| New | +$39.7K |
|
1064
Cidara Therapeutics
CDTX
$1.61B
| $39.7K | ﹤0.01% |
+1,561
| New | +$39.7K |
|
1065
Adaptive Biotechnologies
ADPT
$1.89B
| $39.5K | ﹤0.01% |
4,478
-34,311
| -88% | -$303K |
|
1066
Theravance Biopharma
TBPH
$687M
| $39.2K | ﹤0.01% |
+3,612
| New | +$39.2K |
|
1067
Sypris Solutions
SYPR
$44.9M
| $39.2K | ﹤0.01% |
19,991
-24,199
| -55% | -$47.4K |
|
1068
Church & Dwight Co
CHD
$22.7B
| $39.2K | ﹤0.01% |
443
-5,387
| -92% | -$476K |
|
1069
Traeger
COOK
$178M
| $38.9K | ﹤0.01% |
9,460
-7,746
| -45% | -$31.8K |
|
1070
FreightCar America
RAIL
$159M
| $38.5K | ﹤0.01% |
12,344
-31,465
| -72% | -$98.2K |
|
1071
OppFi
OPFI
$289M
| $38.5K | ﹤0.01% |
+18,785
| New | +$38.5K |
|
1072
Immunome
IMNM
$783M
| $38.4K | ﹤0.01% |
7,705
+5,529
| +254% | +$27.6K |
|
1073
Kilroy Realty
KRC
$4.98B
| $38.3K | ﹤0.01% |
+1,181
| New | +$38.3K |
|
|
SRTA
1074
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$326M
| $38.2K | ﹤0.01% |
+11,308
| New | +$38.2K |
|
|
SFT
1075
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $38.1K | ﹤0.01% |
34,062
-22,213
| -39% | -$24.9K |
|